(Q38609692)

English

Management of ceritinib therapy and adverse events in patients with ALK-rearranged non-small cell lung cancer.

scientific article published on 09 June 2017

In more languages
default for all languages
No label defined

No description defined

Statements

Management of ceritinib therapy and adverse events in patients with ALK-rearranged non-small cell lung cancer (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit